Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03599661 · ClinicalTrials.gov registry record
Developing and Validating Fertilit-e
A clinical trial, sponsored by Wake Forest University Health Sciences.
- Terminated
- Registry status
- 21
- Enrollment target
NCT03599661: Clinical Trial study, sponsored by Wake Forest University Health Sciences.
NCT03599661 is a clinical trial that was terminated before completion, run by Wake Forest University Health Sciences. The registered enrollment target is 21 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03599661 was terminated before completion, sponsored by Wake Forest University Health Sciences.
- TERMINATED
- Registry status
- 21 participants
- Enrollment target
Study Summary
The main purpose of this project is to adapt and validate an eHealth fertility preservation decision-making support tool (Fertilit-e) for young adults with cancer.
Primary Outcome
To evaluate Fertilit-e alpha, we will examine its usability through a series of think aloud interviews. Qualitative analysis will provide an integrative summary and identification of key points, potential themes, and areas of further exploration.
Interventions
- OTHER Questionnaire Administration
- OTHER Interview
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2018-08-15 |
| Est. Completion | 2023-06-07 |
Why NCT03599661 stopped before completion
NCT03599661 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 21 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Questionnaire Administration is the first listed.
NCT03599661 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03599661 about?
NCT03599661 is a clinical study titled "Developing and Validating Fertilit-e". The main purpose of this project is to adapt and validate an eHealth fertility preservation decision-making support tool (Fertilit-e) for young adults with cancer.
What is the current status of trial NCT03599661?
This trial is currently terminated. The enrollment target is 21 participants. The study started on 2018-08-15. Estimated completion is 2023-06-07.
What interventions are being tested in trial NCT03599661?
The interventions under investigation include: Questionnaire Administration (OTHER), Interview (OTHER).
Who is sponsoring clinical trial NCT03599661?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI